VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Clinical trial NCT04433156 · COMPLETED
Trial details
- NCT number
- NCT04433156
- Sponsor
- Henan Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-22
- Primary completion
- 2025-07-31
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.